|
RNF170 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.60445007174803E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87270199347722E-11 |
| Normal-vs-Stage2 |
8.52610204660209E-11 |
| Normal-vs-Stage3 |
2.91422441733857E-12 |
| Normal-vs-Stage4 |
8.32667268468867E-15 |
| Stage1-vs-Stage2 |
3.702200E-01 |
| Stage1-vs-Stage3 |
1.541380E-01 |
| Stage1-vs-Stage4 |
1.039450E-03 |
| Stage2-vs-Stage3 |
8.838000E-01 |
| Stage2-vs-Stage4 |
1.521010E-01 |
| Stage3-vs-Stage4 |
1.100630E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.77653464056493E-12 |
| Normal-vs-AfricanAmerican |
3.52930000000473E-05 |
| Normal-vs-Asian |
8.01736455002811E-12 |
| Caucasian-vs-AfricanAmerican |
2.482800E-01 |
| Caucasian-vs-Asian |
6.942200E-01 |
| AfricanAmerican-vs-Asian |
2.282400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.80697687315978E-12 |
| Normal-vs-Female |
3.67084140862062E-12 |
| Male-vs-Female |
4.201600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.5014989251938E-11 |
| Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(61-80Yrs) |
3.65596442009064E-13 |
| Normal-vs-Age(81-100Yrs) |
2.381200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.427400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.420800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.581000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.105400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.262600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.295600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.849700E-04 |
| Classical-VS-Follicular |
3.885800E-01 |
| Classical-VS-Other |
2.442600E-01 |
| Classical-VS-Normal |
1.00980002137874E-10 |
| Tall-VS-Follicular |
2.013800E-02 |
| Tall-VS-Other |
7.610600E-01 |
| Tall-VS-Normal |
5.6843418860808E-14 |
| Follicular-VS-Other |
4.489600E-01 |
| Follicular-VS-Normal |
3.81694675866129E-12 |
| Other-VS-Normal |
3.970300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.78688225011592E-12 |
| Normal-vs-N1 |
1.80355730350357E-12 |
| N0-vs-N1 |
9.604400E-02 |
|
|
